Osteoprotegerin and RANKL serum concentrations in neonates of mothers with early-onset pre-eclampsia: comparison with neonates of normotensive mothers. (August 2019)
- Record Type:
- Journal Article
- Title:
- Osteoprotegerin and RANKL serum concentrations in neonates of mothers with early-onset pre-eclampsia: comparison with neonates of normotensive mothers. (August 2019)
- Main Title:
- Osteoprotegerin and RANKL serum concentrations in neonates of mothers with early-onset pre-eclampsia: comparison with neonates of normotensive mothers
- Authors:
- Oikonomou, Nikoleta
Papadopoulou, Chrysanthi
Fouzas, Sotirios
Kritikou, Dimitra
Chrysis, Dionisios
Sinopidis, Xenophon
Dimitriou, Gabriel
Karatza, Ageliki A. - Abstract:
- Abstract: Background: Pre-eclampsia is a known risk factor for long-term cardiovascular complications. Osteoprotegerin (OPG) and the receptor activator of nuclear factor κB ligand (RANKL) have been implicated in the pathogenesis of cardiovascular disease. The OPG-RANKL axis function is also altered in pregnant women with pre-eclampsia, but there is lack of data regarding OPG and RANKL concentrations in their neonates. Aims: To examine the effects of early-onset pre-eclampsia on OPG and RANKL serum concentrations at birth, taking into account the influence of various perinatal factors. Study design: OPG and RANKL serum concentrations were measured in 28 premature newborns of mothers with early onset pre-eclampsia, and in 28 preterm and 28 full-term neonates of normotensive mothers (control groups). Results: Neonates of pre-eclamptic mothers had higher OPG and lower RANKL levels compared to both control groups (Kruskal-Wallis P < 0.0001 and P = 0.014, respectively). Regression analysis showed that pre-eclampsia (P < 0.0001), birth weight z-score (P = 0.048) and antenatal steroid administration (P = 0.034) were significant determinants of OPG levels. Multivariable regression analysis also showed that pre-eclampsia was an independent predictor of increased diastolic and mean blood pressure in these neonates. Conclusions: Early-onset pre-eclampsia affects OPG concentrations at birth and is an independent predictor of increased blood pressure in the offspring. Our findings suggestAbstract: Background: Pre-eclampsia is a known risk factor for long-term cardiovascular complications. Osteoprotegerin (OPG) and the receptor activator of nuclear factor κB ligand (RANKL) have been implicated in the pathogenesis of cardiovascular disease. The OPG-RANKL axis function is also altered in pregnant women with pre-eclampsia, but there is lack of data regarding OPG and RANKL concentrations in their neonates. Aims: To examine the effects of early-onset pre-eclampsia on OPG and RANKL serum concentrations at birth, taking into account the influence of various perinatal factors. Study design: OPG and RANKL serum concentrations were measured in 28 premature newborns of mothers with early onset pre-eclampsia, and in 28 preterm and 28 full-term neonates of normotensive mothers (control groups). Results: Neonates of pre-eclamptic mothers had higher OPG and lower RANKL levels compared to both control groups (Kruskal-Wallis P < 0.0001 and P = 0.014, respectively). Regression analysis showed that pre-eclampsia (P < 0.0001), birth weight z-score (P = 0.048) and antenatal steroid administration (P = 0.034) were significant determinants of OPG levels. Multivariable regression analysis also showed that pre-eclampsia was an independent predictor of increased diastolic and mean blood pressure in these neonates. Conclusions: Early-onset pre-eclampsia affects OPG concentrations at birth and is an independent predictor of increased blood pressure in the offspring. Our findings suggest that altered OPG-RANKL axis function may be one of the mechanisms of cardiovascular 'programming' in fetuses exposed to pre-eclampsia. Highlights: OPGRANKL have been implicated in the pathogenesis of cardiovascular disease Serum OPG and OPG/RANKL are higher in newborns exposed to early-onset pre-eclampsia Pre-eclampsia is an independent predictor of high blood pressure in the offspring OPG may be involved in the cardiovascular 'programming' of pre-eclamptic fetuses … (more)
- Is Part Of:
- Early human development. Volume 135(2019)
- Journal:
- Early human development
- Issue:
- Volume 135(2019)
- Issue Display:
- Volume 135, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 135
- Issue:
- 2019
- Issue Sort Value:
- 2019-0135-2019-0000
- Page Start:
- 1
- Page End:
- 5
- Publication Date:
- 2019-08
- Subjects:
- PE pre-eclampsia -- OPG osteoprotegerin -- RANKL receptor activator of nuclear factor κB ligand -- AGA appropriate for gestational age
Pre-eclampsia -- Osteoprotegerin -- Blood pressure -- Prematurity
Fetus -- Periodicals
Neonatology -- Periodicals
Prenatal influences -- Periodicals
612.65 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03783782 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.earlhumdev.2019.06.001 ↗
- Languages:
- English
- ISSNs:
- 0378-3782
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3642.983000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11040.xml